Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF), a leader in the production of pharmaceutical cannabidiol (CBD) products and in the development of innovative cannabidiol medicines for heart disease, is pleased to announce the formation of the Clinical Steering Committee (CSC) for a Phase 2 international trial in acute myocarditis using the Companys CardiolRx100 cannabidiol formulation.
The CSC, which comprises key opinion leaders in acute myocarditis from North America and Europe, recently met during the American Heart Associations Scientific Sessions in Philadelphia held November 16th to 18th. The role of the CSC is to advise on the trial design, provide overall supervision of the trial, and ensure that it is being conducted in accordance with the principles of Good Clinical Practice. The CSC has oversight of the protocol, any protocol amendments, and provides advice to the investigators on all aspects of the trial.
Acute myocarditis is characterized by inflammation of the heart muscle (myocardium). The most common cause is viral infection of the heart tissue which is initially responsible for the inflammation. In a significant number of cases, perhaps due to an autoimmune process, the inflammation persists with ongoing myocardial damage and depressed heart function. Although the symptoms are often mild, myocarditis remains an important cause of acute and fulminant heart failure and is the most common cause of sudden cardiac death in people less than 35 years old. In addition, some patients proceed to develop chronic dilated cardiomyopathy which continues to be the leading indication for cardiac transplantation. Symptoms include chest pain, fatigue, shortness of breath, and arrhythmias. Because of the progressive damage to heart cells, heart failure develops (defined as the inability of the heart to pump sufficient blood to meet the needs of the body). The study will use left ventricular ejection fraction (LVEF) as one measure of heart function.
CardiolRx100 is Cardiol Therapeutics pure pharmaceutically (cGMP) produced high concentration cannabidiol formulation that is THC free (<10ppm). Based on the large body of experimental evidence of the anti-inflammatory and cardioprotective properties of cannabidiol in models of cardiovascular disease, Cardiol believes there is an opportunity to develop a potential breakthrough therapy for acute myocarditis that would be eligible for designation as an orphan drug. In the United States, an orphan drug designation is granted for pharmaceuticals being developed to treat medical conditions affecting fewer than 200,000 people. These conditions are referred to as orphan diseases. In the U.S. and the European Union, orphan drugs are eligible for accelerated marketing approvals and companies developing orphan drugs typically receive other incentives, including a prolonged period of market exclusivity that can extend over seven years, during which the drug developer has sole rights to market the drug.
Cardiol has assembled eight highly distinguished thought leaders in cardiology from North America and Europe to oversee and guide our acute myocarditis trial that is being planned at world leading heart institutes, including the Cleveland Clinic, the Mayo Clinic, the Houston Methodist DeBakey Heart and Vascular Center, the University of Ottawa Heart Institute, and Charit University Medicine Berlin, stated David Elsley, President and CEO of Cardiol Therapeutics. The U.S. orphan drug program was successfully utilized to accelerate the first FDA approval of cannabidiol for the treatment of two pediatric epilepsy orphan diseases. We see a similar opportunity with our international trial in acute myocarditis to fast track the development of our CardiolRx formulation for a serious cardiovascular orphan disease for which there is currently no accepted standard of care.
Members of Cardiols Acute Myocarditis CSC include:
Dennis M. McNamara, MD (Chair)
Dr. Dennis McNamara is a Professor of Medicine at the University of Pittsburgh. He is also the Director of the Heart Failure/Transplantation Program at the University of Pittsburgh Medical Center. Dr. McNamara received his undergraduate/graduate education at Yale University, New Haven, Connecticut, and Harvard Medical School, Boston, Massachusetts, respectively. He completed his internship, residency, and cardiology fellowship at Massachusetts General Hospital in Boston. McNamaras current research interests include etiology and pathogenesis of dilated cardiomyopathies; inflammatory syndromes of cardiovascular disease; myocardial recovery in recent onset non-ischemic primary cardiomyopathy; etiology and management of peripartum cardiomyopathy; and genetic modulation of outcomes in cardiovascular disease.
Leslie T. Cooper, Jr., MD (Co-Chair)
Dr. Leslie T. Cooper, Jr., is a general cardiologist and the chair of the Mayo Clinic Enterprise Department of Cardiovascular Medicine, as well as chair of the Department of Cardiovascular Medicine at the Mayo Clinic in Florida. Dr. Coopers clinical interests and research focus on clinical and translational studies of rare and undiagnosed cardiomyopathies, myocarditis, and inflammatory cardiac and vascular diseases, such as giant cell myocarditis, cardiac sarcoidosis, eosinophilic myocarditis, and Takayasus arteritis. He has published over 130 original peer-reviewed papers, as well as contributing to and editing books on myocarditis. In addition to his clinical and research work, Dr. Cooper is a fellow of the American College of Cardiology, the American Heart Association, the European Society of Cardiology Heart Failure Association, the International Society for Heart and Lung Transplantation, and the Society for Vascular Medicine and Biology. He is also the founder and former president of the Myocarditis Foundation and continues to serve on its Board of Directors.
Arvind Bhimaraj, MD
Dr. Arvind Bhimaraj is a specialist in Heart Failure and Transplantation Cardiology and is Assistant Professor of Cardiology, Institute for Academic Medicine, at Houston Methodist and at Weill Cornell Medical College, NYC. He has been Co-Director of the Heart Failure Research Laboratory at Houston Methodist since 2016. His area of focus is anti-fibrotic mechanisms and how to promote recovery of a damaged heart. Dr. Bhimaraj was a Heart Failure Fellow at the Cleveland Clinic from July 2010 to September 2011. Dr. Bhimaraj also specializes in Interventional Cardiology, is board certified in Cardiovascular Disease, and the author of numerous cardiovascular publications.
Matthias Friedrich, MD
Dr. Matthias Friedrich is Full Professor with the Departments of Medicine and Diagnostic Radiology at the McGill University in Montreal and Chief, Cardiovascular Imaging at the McGill University Health Centre. He is also Professor of Medicine at Heidelberg University in Germany. Dr. Friedrich earned his MD at the Friedrich-Alexander-University Erlangen-Nrnberg, Germany. He completed his training as an internist and cardiologist at the Charit University Medicine Center, Humboldt University in Berlin. Dr. Friedrich founded one of the first large Cardiovascular Magnetic Resonance centres in Germany at the Charit University Hospital in Berlin. After his move to Canada, from 2004 to 2011, he was Director of the Stephenson Cardiovascular MR Centre at the Libin Cardiovascular Institute of Alberta and Professor of Medicine within the Departments of Cardiac Sciences and Radiology at the University of Calgary, Canada. From 2011 to 2015, he directed the Philippa and Marvin Carsley Cardiovascular MR Centre at the Montreal Heart Institute and was Michel and Renata Hornstein Chair in Cardiac Imaging at the Universit de Montral.
Peter Liu, MD
Dr. Peter Liu is the Chief Scientific Officer and Vice President, Research, of the University of Ottawa Heart Institute, and Professor of Medicine and Physiology at the University of Toronto and University of Ottawa. He was the former Scientific Director of the Institute of Circulatory and Respiratory Health at the Canadian Institutes of Health Research, the major federal funding agency for health research in Canada. Prior to that role, he was the inaugural Director of the Heart & Stroke/Lewar Centre of Excellence in Cardiovascular Research at University of Toronto. Dr. Liu received his MD from the University of Toronto, and postgraduate training at Harvard University. His laboratory investigates the causes and treatments of heart failure, the role of inflammation, and the identification of novel biomarkers and interventions in cardiovascular disease. Dr. Liu has published over 300 peer-reviewed articles in high impact journals and received numerous awards in recognition of his research and scientific accomplishments.
Wai Hong Wilson Tang, MD
Dr. Wai Hong Wilson Tang is the Advanced Heart Failure and Transplant Cardiology specialist at the Cleveland Clinic in Cleveland, Ohio. Dr. Tang is also the Director of the Cleveland Clinics Center for Clinical Genomics; Research Director, and staff cardiologist in the Section of Heart Failure and Cardiac Transplantation Medicine in the Sydell and Arnold Miller Family Heart & Vascular Institute at the Cleveland Clinic. He attended and graduated from Harvard Medical School in 1996, having over 23 years of diverse experience, especially in Advanced Heart Failure and Transplant Cardiology. Dr. Tang is affiliated with many hospitals including the Cleveland Clinic and cooperates with other doctors and physicians in medical groups including The Cleveland Clinic Foundation.
Barry Trachtenberg, MD
Dr. Barry H. Trachtenberg is a cardiologist specializing in heart failure and cardiac transplantation. He is also the director of the Michael DeBakey Cardiology Associates Cardio-Oncology program, an evolving field devoted to prevention and management of cardiovascular complications of cancer therapies such as chemotherapy and radiation. His clinical experience includes heart failure and heart transplantation, mechanical support pumps, and cardio-oncology. He has contributed to multiple publications related to advanced heart failure, cardiac transplantation, regenerative therapies, and ventricular assist devices. Dr. Trachtenberg is a member of the American Heart Association, the International Society for Heart and Lung Transplantation, the Heart Failure Society of America, and the International CardiOncology Society of North America.
Carsten Tschpe, MD
Dr. Carsten Tschpe is Professor of Medicine and Cardiology and Vice Director of the Department of Internal Medicine and Cardiology, Charit University Medicine Berlin. He received his doctorate in medicine in 1993 and has over 140 peer-reviewed publications, including overview and book articles, and 120 international original articles. His research interests include inflammatory cardiomyopathy, diabetic cardiopathy, and ischemic cardiopathy. He also includes diastolic dysfunction, endothelial dysfunction, peptide systems, and experimental and clinical studies in cardiology and stem cells in his research studies. For his outstanding research work, Dr. Tschpe was awarded the prestigious Arthur Weber Prize by the German Cardiac Society Cardiovascular Research.
About Cardiol Therapeutics
Cardiol Therapeutics Inc. (TSX: CRDL)(OTCQX: CRTPF) is focused on producing pharmaceutical cannabidiol (CBD) products and developing innovative therapies for heart disease, including acute myocarditis and other causes of heart failure. The Companys lead product, CardiolRx, is designed to be one of the safest and most consistent CBD formulations on the market. CardiolRx is pharmaceutically produced, cGMP certified, and is THC free. The Company plans to commercialize CardiolRx in the billion-dollar market for medicinal cannabinoids in Canada and is also pursuing distribution opportunities in Europe and Latin America.
In heart failure, Cardiol is planning an international clinical study of CardiolRx in acute myocarditis, a condition caused by inflammation in heart tissue, which remains the most common cause of sudden cardiac death in people less than 35 years of age. The Company is also developing proprietary nanotechnology to uniquely deliver pharmaceutical CBD and other anti-inflammatory drugs directly to sites of inflammation in the heart that are associated with heart failure. Heart failure is the leading cause of death and hospitalization in North America with associated healthcare costs in the U.S. alone exceeding $30 billion. For further information about Cardiol Therapeutics, please visitwww.cardiolrx.com.
- Croydon mum's urgent appeal for stem cell donors who could save her two-year-old daughter - My London - August 5th, 2020
- Celularity announces the activation of first California Clinical Trial Site following CIRM Grant Award to Advance Treatments for COVID-19 - Yahoo... - August 5th, 2020
- 'Year of Preparations for the Next Fifty Years' will contribute to countrys development process - Emirates 24|7 - August 4th, 2020
- Incyte/Morphosys take on CAR-Ts with $198,000 per year antibody - - pharmaphorum - August 3rd, 2020
- Crowdfunding to the rescue for this cancer patient - Telangana Today - August 3rd, 2020
- Global Multiple Myeloma Treatment Market-Industry Analysis and forecast 2019 2027: By Application, Type, and Region. - Red & Black Student... - August 3rd, 2020
- stem cell doctor - regenexx.com - August 2nd, 2020
- Former SEC Head Coach, AD Hospitalized With COVID-19 - The Spun - August 1st, 2020
- Think You Might Have NMOSD? Diagnosis May Take a While - HealthCentral.com - August 1st, 2020
- Global Cell Therapy Systems Market Projected to Witness a Measurable Downturn; COVID-19 Outbreak Remains a Threat to Growth in the Near Future... - July 31st, 2020
- Crowdfunding to the rescue for this cancer patient - Social News XYZ - July 30th, 2020
- Precision Medicine Achieves Our Goals and Makes Money in Stocks - Banyan Hill Publishing - July 30th, 2020
- Crowdfunding to the rescue for this cancer patient - Daijiworld.com - July 30th, 2020
- Shady Stem Cell Therapies Can Cause tumours, Infections ... - July 30th, 2020
- Digong forgot to mention the cure for Covid-19 The Manila Times - The Manila Times - July 29th, 2020
- Shady Stem Cell Therapies Can Cause Tumors, Infections, and Death, Doctors Report - Gizmodo - July 29th, 2020
- R3 Stem Cell International Now Offering Four Joint Injections for Only $3950 in Mexico - Yahoo Finance - July 29th, 2020
- UAE's first bone marrow transplant patient tells of life-saving treatment - The National - July 29th, 2020
- From cancer through Covid, how one mother retained hope - Buffalo News - July 29th, 2020
- Mum whose husband died of coronavirus shares heartbreaking video of one-year-old son saying Dada as his fir - The Irish Sun - July 27th, 2020
- Scientists discover why coronavirus patients lose sense of smell and offer hope to those who havent got it - The Scottish Sun - July 27th, 2020
- Fair Haven Foundation provides a refuge in the storm - WRTV Indianapolis - July 27th, 2020
- 'Healthy' mum diagnosed with cancer so aggressive it cracked several ribs - Mirror Online - July 26th, 2020
- AIIMS Delhi Indias best medical college thats home to many leaders of Covid battle - ThePrint - July 26th, 2020
- Cancer struck Welsh mum so aggressively it cracked her ribs and damaged her spine - North Wales Live - July 25th, 2020
- 12 Incredible inventions to make you feel Proudly South African - The South African - July 25th, 2020
- Mum had tumour so big it cracked her ribs - Wales Online - July 25th, 2020
- Two people receive helping hand from Centre to get their advanced treatment in Delhi amid COVID-19 lockdown - Yahoo India News - July 24th, 2020
- First Edition: July 24, 2020 - Kaiser Health News - July 24th, 2020
- Shifting the focus in healthcare to primordial prevention - ETHealthworld.com - July 24th, 2020
- 'We are worried for what lies ahead' say Harrow parents in donor plea for son, 4 - My London - July 23rd, 2020
- A brief history of racism in healthcare - World Economic Forum - July 23rd, 2020
- Two Cases Of West Nile Virus Confirmed In Greece Greek City Times - GreekCityTimes.com - July 22nd, 2020
- Greek Scientists Concerned By The "orphan" Covid-19 Cases - GreekCityTimes.com - July 22nd, 2020
- Greek Sailors Trapped In The Middle Of The Ocean For Months Due To Coronavirus - GreekCityTimes.com - July 22nd, 2020
- The Latest: At a Texas federal prison, more than 500 women test positive for virus - Press Herald - July 21st, 2020
- 3 Ways Predictive Analytics is Advancing the Healthcare Industry - HealthITAnalytics.com - July 21st, 2020
- Hypoxia Market 2020 How the Market has witnessed Substantial Growth in Recent Years? - Cole of Duty - July 21st, 2020
- Short-staffed healthcare system to get 2,000 new nurses, 400 more doctors - The Times of Israel - July 20th, 2020
- Cancer-surviving singer gives back to Leukemia and Lymphoma Society | Artists of the Island - silive.com - July 19th, 2020
- Artificial Blood Market Excellent Growth 2024 | also understand the impact of COVID-19 situation across the globe - 3rd Watch News - July 18th, 2020
- Felipe Massa gives rare insight into Michael Schumachers condition and recovery - Mirror Online - July 18th, 2020
- The International Space Station creates bigger, colder states of matter than are possible on Earth - Massive Science - July 17th, 2020
- Out-of-Pocket Costs Often Higher Than Expected for Patients with Cancer Participating on Clinical Trials - Curetoday.com - July 17th, 2020
- Biotechnology Reagents Market To Witness Massive Growth Worldwide | Global Players Abbott, Agilent Technologies Inc., Danaher, Bd, Bio-Rad... - July 17th, 2020
- Fear, Courage, Grit: Meet More Than 50 'Hospital Heroes' - WTOP - July 17th, 2020
- Why is this nebula shaped like a butterfly? - Massive Science - July 16th, 2020
- Anaplastic Large Cell Lymphoma Alcl Therapeutics Market is Set to Experience Revolutionary Growth by 2026 - Cole of Duty - July 16th, 2020
- 'I don't have much time. I need a miracle' why stem cell donors are urgently needed - The Times - July 15th, 2020
- With rise in Covid cases, Surat to add 1,570 beds in 2 hospitals - The Indian Express - July 15th, 2020
- It's past time to treat international students as more than just money makers for universities - Massive Science - July 15th, 2020
- Scientists have made an important discovery for the treatment of male infertility - The Saxon - July 14th, 2020
- Tummy Ache Turns Out To Be Cancer, ER Visit During Pandemic Was Critical Decision - CBS Denver - July 14th, 2020
- One common infection could kill our baby girl but one simple act could change her life forever - The Sun - July 14th, 2020
- Top 10 Most Popular Stem Cell Treatments of 2020 - July 13th, 2020
- Coronavirus updates: California to release 8,000 inmates; masks 'only way' to prevent another shutdown, Texas Gov. says - Times Record News - July 13th, 2020
- Actor Nick Cordero Has Died from COVID-19 Complications After 13 Weeks in the Hospital - Yahoo India News - July 12th, 2020
- Ryan Anthony: A local trumpet prodigy who went on to play big stages and raise funds for cancer research - The San Diego Union-Tribune - July 11th, 2020
- The 'Teeter-Totter' of Blood Draws - Curetoday.com - July 11th, 2020
- In the middle of pandemic, this young mom fights second cancer diagnosis - Omaha World-Herald - July 11th, 2020
- R3 International Now Offering Stem Cell Therapy Program for Crohns Disease, IBD and Ulcerative Colitis - PR Web - July 10th, 2020
- Eucalyptus necklace and other unproven Covid-19 cures raise alarm in Indonesia - The Star Online - July 10th, 2020
- Surat: Engineer falls to death from tenth floor of under construction Covid hospital - The Indian Express - July 10th, 2020
- Tribute to Andra Campbell after five-year cancer battle | Romsey Advertiser - Romsey Advertiser - July 10th, 2020
- IML conducts the 5th National Convention on Medicine and Law - ETHealthworld.com - July 10th, 2020
- R3 International Now Offering Stem Cell Therapy Program for Crohns Disease, IBD and Ulcerative Colitis - Benzinga - July 9th, 2020
- Stem Cell Therapy Market : Global Forecast over 2025 Cole of Duty - Cole of Duty - July 9th, 2020
- Whatever happened to baby Owen? - The Herald-News - July 9th, 2020
- University of Miami Miller School-led technology paves way for islet regeneration in human pancreas - Newswise - July 9th, 2020
- Here's Why Mesoblast Stock Rose Over 18% Today - The Motley Fool - July 9th, 2020
- Eucalyptus necklace and other unproven Covid-19 cures raise alarm in Indonesia - The Straits Times - July 9th, 2020
- Global Organ Preservation Market Future Demand (COVID 19 Impact Analysis) & Growth Analysis with Forecast up to 2027 - Cole of Duty - July 9th, 2020
- First time ever successful operation with a single-use endoscope on immunodepressed child - Emergency-Live - July 4th, 2020
- College Kids Are Apparently Playing a Game Where They Try to Catch COVID - Futurism - July 3rd, 2020
- A Shot of This Gene Editing Serum Appears to Prevent Heart Disease in Monkeys - Futurism - July 3rd, 2020
- Katharine McPhee reveals frustrations with husband David Foster in new documentary - Wonderwall - July 3rd, 2020
- Jada Pinkett Smith denies August Alsina's claim they had years-long relationship with Will Smith's blessing - Wonderwall - July 3rd, 2020
- Global Bronchopulmonary Dysplasia Treatment Market Projected to Witness a Measurable Downturn; COVID-19 Outbreak Remains a Threat to Growth in the... - July 3rd, 2020
- Its not just the lungs: COVID-19 can affect the brain and heart of those infected, researchers say - WITI FOX 6 Milwaukee - July 2nd, 2020
- Inequality in COVID-19 Has Other Dangerous Consequences - Fox and Hounds Daily - July 2nd, 2020